Drugs / chitosan nanoparticles
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03719261 | Nov 2018 → Apr 2019 | — | Cairo University | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03588351 | Jan → Aug 2018 | dental pulp necrosis | Ain Shams University | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT06777303 Comparator | Jun 2024 → Aug 2025 overdue | periodontitis | Mansoura University | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chitosan nanoparticles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03588351 ↗ |
| Known as | CS-np | “A randomized clinical trial that aims to study the effect of chitosan nanoparticles (CS-np) versus sodium hypochlorite as a root canal irrigant on postoperative pain and...” NCT03719261 ↗ |
| Modality | Other / unclassified | “Chitosan nanoparticle is a bioactive and environment friendly material with unique physicochemical properties .” NCT03588351 ↗ |
| Route | Other | “chitosan nanoparticles that ready to use as intracanal medicament.” NCT03588351 ↗ |